Chief Financial Officer
Mr. Kokrhoun joined Merz in May 2020 as Chief Financial Officer for Merz Aesthetics. In his role, he is responsible for financial reporting, governance and strategic planning as well as driving financial systems and process automation.
Mr. Kokrhoun comes to Merz Aesthetics from Novartis, where he served as the Global Head of Finance of the Biologics Technical Department. In this role, he oversaw the financial strategy for the Biologics Technical Department and played an active role as a core member of the Functional Leadership Team. Over the course of his nearly 28-year tenure at Novartis and Novartis-owned companies, Mr. Kokrhoun has acquired a broad range of experience and served in many financial roles of increasing responsibility, including as CFO of Vaccines and Diagnostics U.S. where he was essential in integrating Chiron into Novartis.
Mr. Kokrhoun earned his undergraduate degree in business administration from the Munich University of Applied Sciences.